Frontiers in Microbiology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 3, 2025
Background
Rheumatoid
arthritis
(RA)
is
a
persistent
autoimmune
disorder
marked
by
inflammation
and
joint
damage.
Although
current
treatments,
such
as
disease-modifying
antirheumatic
drugs
(DMARDs),
help
control
symptoms,
they
frequently
cause
substantial
side
effects,
highlighting
the
urgent
need
for
safer
more
effective
alternatives.
Recent
research
indicates
that
gut
microbiota
might
be
pivotal
in
RA
development
through
“gut-joint
axis,”
presenting
novel
therapeutic
possibilities.
Purpose
This
study
seeks
to
explore
potential
of
traditional
Chinese
medicine
(TCM)
compound
new
bitongling
(NBTL)
RA,
with
an
emphasis
on
its
capacity
regulate
suppress
angiogenesis
via
vascular
endothelial
growth
factor
(VEGF)
signaling
pathway.
Methods
We
utilized
collagen-induced
(CIA)
rat
model
assess
impact
NBTL.
The
employed
16S
ribosomal
DNA
(16S
rDNA)
sequencing
analyze
composition,
machine
learning
techniques
identify
characteristic
microbial
taxa,
transcriptomic
analysis
(GSVA)
VEGF
findings
were
further
validated
deep
neural
network
models
vivo
/
vitro
experiments,
including
western
blot,
immunofluorescence,
miRNA
analysis.
Results
NBTL
treatment
markedly
diminished
rats,
evidenced
reduced
expression
TNF-α,
IL-17,
IL-6,
ASC
synovial
tissues.
Histopathological
confirmed
alleviation
Five
f_Mycoplasmataceae
,
s_Metamycoplasma_sualvi
g_Prevotellaceae_Ga6A1_group
identified
associated
NBTL’s
modulation
Gene
set
variation
revealed
significant
downregulation
pathway
following
treatment.
Subsequent
experiments
inhibited
receptors,
VEGFR1
VEGFR2,
along
HIF-1α
(hypoxia-inducible
1-alpha),
thereby
reducing
angiogenesis.
Additionally,
upregulated
miR-20a-5p
miR-223-3p,
contributing
anti-angiogenic
effects.
Conclusion
exhibits
modulating
inhibiting
These
support
use
promising
candidate
treatment,
emphasizing
mechanisms
clinical
application.
ACS Nano,
Journal Year:
2024,
Volume and Issue:
18(5), P. 4019 - 4037
Published: Jan. 22, 2024
Pancreatic
ductal
adenocarcinoma
(PDAC)
is
notorious
for
its
resistance
against
chemotherapy
and
immunotherapy
due
to
dense
desmoplastic
immunosuppressive
tumor
microenvironment
(TME).
Traditional
photodynamic
therapy
(PDT)
was
also
less
effective
PDAC
owing
poor
selectivity,
insufficient
penetration,
accumulation
of
photosensitizers
in
sites.
Here,
we
designed
a
light-responsive
novel
nanoplatform
targeting
the
TME
through
tumor-specific
midkine
nanobodies
(Nbs),
which
could
efficiently
deliver
semiconducting
polymeric
nanoparticles
(NPs)
locally
produce
abundant
reactive
oxygen
species
(ROS)
precise
photoimmunotherapy.
The
synthesized
nanocomposite
can
not
only
achieve
multimodal
imaging
tumors
(fluorescence
photoacoustic
imaging)
but
lead
apoptosis
immunogenic
cell
death
cells
via
ROS
under
light
excitation,
ultimately
preventing
progression
remodeling
with
increased
infiltration
T
lymphocytes.
Combined
PD-1
checkpoint
blockade,
targeted
PDT
platform
showed
best
antitumor
performance
markedly
extended
mice
survival.
Conclusively,
this
work
integrating
Nbs
NPs
provides
strategy
target
formidable
suppression
activate
immunity,
creating
possibilities
boosting
efficacy
combination
local
PDT.
Nature Communications,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Jan. 2, 2025
Ovarian
function
declines
significantly
as
females
enter
middle-age,
but
the
mechanisms
underlying
this
decline
remain
unclear.
Here,
we
utilize
whole-organ
imaging
to
observe
a
notable
decrease
in
ovarian
blood
vessel
(oBV)
density
and
angiogenesis
intensity
of
middle-aged
mice.
This
leads
diminished
supply
ovaries,
resulting
inadequate
development
maturation
follicles.
Utilizing
genetic-modified
mouse
models,
demonstrate
that
granulosa
cell
secreted
VEGFA
governs
angiogenesis,
physiological
oBV
is
not
attributed
insufficiency.
Instead,
through
single-cell
sequencing,
identify
aging
vascular
endothelium
primary
factor
contributing
decline.
Consequently,
administration
salidroside,
natural
compound
functional
reverse
promote
enhances
improve
fertility
older
females.
Our
findings
highlight
enhancing
promising
strategy
boost
study
identifies
key
driver
loss
female
mice
demonstrates
restoring
with
Salidroside
might
be
approach
aged
Molecular Aspects of Medicine,
Journal Year:
2025,
Volume and Issue:
101, P. 101335 - 101335
Published: Jan. 1, 2025
Renal
cell
carcinoma
(RCC)
is
a
malignant
tumor
with
highly
heterogeneous
and
complex
molecular
mechanisms.
Through
systematic
analysis
of
TCGA,
COSMIC
other
databases,
24
mutated
genes
closely
related
to
RCC
were
screened,
including
VHL,
PBRM1,
BAP1
SETD2,
which
play
key
roles
in
signaling
pathway
transduction,
chromatin
remodeling
DNA
repair.
The
PI3K/AKT/mTOR
particularly
important
the
pathogenesis
RCC.
Mutations
such
as
PIK3CA,
MTOR
PTEN
are
associated
metabolic
abnormalities
proliferation.
Clinically,
mTOR
inhibitors
VEGF-targeted
drugs
have
shown
significant
efficacy
personalized
therapy.
Abnormal
regulation
reprogramming,
especially
glycolysis
glutamine
pathways,
provides
cells
continuous
energy
supply
survival
advantages,
GLS1
promising
results
preclinical
studies.
This
paper
also
explores
potential
immune
checkpoint
combination
targeted
drugs,
well
application
nanotechnology
drug
delivery
In
addition,
unique
mechanisms
revealed
individualized
therapeutic
strategies
explored
for
specific
subtypes
TFE3,
TFEB
rearrangement
type
SDHB
mutant
type.
review
summarizes
common
gene
mutations
their
mechanisms,
emphasizes
diagnosis,
treatment
prognosis,
looks
forward
prospects
multi-pathway
therapy,
immunotherapy
treatment,
providing
theoretical
support
clinical
guidance
new
development.
Biomedicine & Pharmacotherapy,
Journal Year:
2023,
Volume and Issue:
170, P. 116024 - 116024
Published: Dec. 19, 2023
Bioactive
macromolecular
drugs
known
as
Growth
Factors
(GFs),
approved
by
the
Food
and
Drug
Administration
(FDA),
have
found
successful
application
in
clinical
practice.
They
hold
significant
promise
for
addressing
peripheral
nerve
injuries
(PNIs).
Peripheral
guidance
conduits
(NGCs)
loaded
with
GFs,
context
of
tissue
engineering,
can
ensure
sustained
efficient
release
these
bioactive
compounds.
This,
turn,
maintains
a
stable,
long-term,
effective
GF
concentration
essential
treating
damaged
nerves.
regeneration
is
complex
process
that
entails
secretion
various
GFs.
Following
PNI,
GFs
play
pivotal
role
promoting
cell
growth
survival,
axon
myelin
sheath
regeneration,
differentiation,
angiogenesis.
also
regulate
regenerative
microenvironment,
stimulate
plasticity
changes
post-nerve
injury,
and,
consequently,
expedite
structure
function
repair.
Both
exogenous
endogenous
including
NGF,
BDNF,
NT-3,
GDNF,
IGF-1,
bFGF,
VEGF,
been
successfully
onto
NGCs
using
techniques
like
physical
adsorption,
blend
doping,
chemical
covalent
binding,
engineered
transfection.
These
approaches
effectively
promoted
repair
Numerous
studies
demonstrated
similar
functional
therapeutic
outcomes
compared
to
autologous
transplantation.
This
evidence
underscores
substantial
potential
domain
In
this
article,
we
provide
an
overview
drug
delivery
systems
utilizing
NGCs.
Looking
ahead,
commercial
materials
facilitate
nerves
maintain
functionality
distant
target
organs
through
Annals of the Rheumatic Diseases,
Journal Year:
2024,
Volume and Issue:
83(7), P. 945 - 956
Published: Feb. 19, 2024
Untreated
gout
is
characterised
by
monosodium
urate
(MSU)
crystal
accumulation
responsible
for
recurrent
flares
that
are
commonly
separated
asymptomatic
phases.
Both
phases
inflammatory
conditions
of
variable
intensity.
Gout
self-limited
reactions
involving
multiple
mediators.
This
study
aimed
to
characterise
the
profiles
at
different
Advanced Functional Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: July 1, 2024
Abstract
Bacterial
infections,
especially
those
from
drug‐resistant
strains,
pose
a
significant
threat
to
healing
diabetic
skin
injuries,
with
current
treatments
being
intricated
and
often
unsatisfactory.
Inspired
by
octopuses,
biomimetic
material
using
α‐cyclodextrin
(α‐CD)
polyethylene
glycol
(PEG)
assembled
graphene
oxide
end‐capped
polyrotaxanes
(GO‐PR)
is
developed,
where
α‐CD
mimics
the
flexible
tentacles
of
an
octopus.
Further,
cationically
modified
polyethyleneimine
(PEI)
resemble
octopus
suction
cups,
creating
GO‐PRP,
which
effectively
captures
adheres
bacteria.
Importantly,
emulate
octopus's
ink
defense,
GO‐PRP
used
as
carrier
for
nitric
(NO),
resulting
in
GO‐PRP/NONOate.
Utilizing
photothermal
conversion
GO,
near‐infrared
light
exposure
triggers
rapid
heating
NO
release,
providing
efficient
antibacterial
activity
biofilm
dispersion,
significantly
reducing
inflammation
injuries
type
I
rats.
During
wound
healing,
sustained
release
promotes
vascular
endothelial
growth
factor
production
blood
vessel
regeneration,
enhancing
collagen
formation
shortening
time
infections.
Thus,
octopus‐inspired
GO‐PRP/NONOate
emerges
novel
biomaterial
treating
bacterial
infections
wounds
biomedical
field.
Pharmacological Research,
Journal Year:
2024,
Volume and Issue:
203, P. 107150 - 107150
Published: March 21, 2024
Cancer,
with
its
diversity,
heterogeneity,
and
complexity,
is
a
significant
contributor
to
global
morbidity,
disability,
mortality,
highlighting
the
necessity
for
transformative
treatment
approaches.
Photodynamic
therapy
(PDT)
has
aroused
continuous
interest
as
viable
alternative
conventional
cancer
treatments
that
encounter
drug
resistance.
Nanotechnology
brought
new
advances
in
medicine
shown
great
potential
delivery
treatment.
For
precise
efficient
therapeutic
utilization
of
such
tumor
approach
high
spatiotemporal
selectivity
minimal
invasiveness,
carrier-free
noncovalent
nanoparticles
(NPs)
based
on
chemo-photodynamic
combination
essential.
Utilizing
natural
products
foundation
nanodrug
development
offers
unparalleled
advantages,
including
exceptional
pharmacological
activity,
easy
functionalization/modification,
well
biocompatibility.
The
natural-product-based,
carrier-free,
NPs
revealed
excellent
synergistic
anticancer
activity
comparison
free
photosensitizers
bioactive
products,
representing
an
favorable
avenue
improve
efficacy.
Herein,
comprehensive
summary
current
strategies
representative
application
examples
past
decade
(such
paclitaxel,
10-hydroxycamptothecin,
doxorubicin,
etoposide,
combretastatin
A4,
epigallocatechin
gallate,
curcumin)
therapy.
We
highlight
insightful
design
synthesis
smart
aim
enhance
PDT
Meanwhile,
we
discuss
future
challenges
opportunities
associated
these
provide
enlightenment,
spur
innovative
ideas,
facilitate
PDT-mediated
clinical
transformation.